Gene therapy restores hearing in deaf children

Gene therapy has shown promising results in restoring hearing in children with congenital deafness. Several clinical trials have been conducted, primarily in China and the United States, with positive outcomes. The therapy involves adding a gene related to the transmission of signals in the ear cells, allowing them to produce a crucial chemical for hearing. So far, the treatment has been successful in improving the hearing abilities of several children, with results ranging from 60% to 65% of normal speech. While the therapy is not suitable for all forms of deafness, the success of these trials has generated excitement and interest in the field of gene therapy for hearing loss.